phenylethyl alcohol has been researched along with Apolipoprotein B-100, Familial Defective in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, T; Hishikawa, K; Nakaki, T | 1 |
1 other study(ies) available for phenylethyl alcohol and Apolipoprotein B-100, Familial Defective
| Article | Year |
|---|---|
Oral flavonoid supplementation attenuates atherosclerosis development in apolipoprotein E-deficient mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Aorta, Thoracic; Aortic Diseases; Apolipoproteins E; Arteriosclerosis; Caffeic Acids; Cell Adhesion Molecules; Cytokines; Depression, Chemical; Drug Evaluation, Preclinical; Extracellular Matrix Proteins; Free Radical Scavengers; Gene Expression Profiling; Gene Expression Regulation; Hyperlipoproteinemia Type II; Isoprostanes; Lipids; Male; Mice; Mice, Knockout; NF-kappa B; Oxidative Stress; Phenylethyl Alcohol; Random Allocation; Transcription Factors | 2005 |